Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T16:36:51.234Z.
Calculation as of: 2026-10-06T16:36:51.234Z.
Quote observation: 2026-10-06T16:35:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5259cb07e2fbb96f0e8f0a81153900e7454c243d03e5865b91db876a0b9f3ffb
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2017-11-07.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$438.81M
EV/FCF Ratio
N/A
TTM Avg
25.38x
3Y Avg
25.38x
5Y Avg
25.38x
Market Cap
$439.74M
EV/FCF Ratio
N/A
TTM Avg
2.71x
3Y Avg
2.71x
5Y Avg
2.71x
Market Cap
$446.65M
EV/FCF Ratio
N/A
TTM Avg
0.21x
3Y Avg
0.21x
5Y Avg
0.21x
Market Cap
$419.05M
EV/FCF Ratio
N/A
TTM Avg
32.08x
3Y Avg
32.08x
5Y Avg
32.08x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | $433.53M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $429.88M | N/A | 51.06x | 46.23x | 33.62x |
| Capricor Therapeutics, Inc. (CAPR)vs › | $438.81M | N/A | 25.38x | 25.38x | 25.38x |
| Assembly Biosciences, Inc. (ASMB)vs › | $439.74M | N/A | 2.71x | 2.71x | 2.71x |
| NeuroPace, Inc. (NPCE)vs › | $445.61M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $421.41M | N/A | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $421.28M | N/A | N/A | N/A | N/A |
| Ovid Therapeutics Inc. (OVID)vs › | $446.65M | N/A | 0.21x | 0.21x | 0.21x |
| Prothena Corporation plc (PRTA)vs › | $419.05M | N/A | 32.08x | 32.08x | 32.08x |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $448.85M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2017-11-07 | 78.23x |
| 2017-11-06 | 81.81x |
| 2017-11-03 | 85.24x |
| 2017-11-02 | 81.47x |
| 2017-11-01 | 79.36x |
| 2017-10-31 | 84.75x |
| 2017-10-30 | 81.36x |
| 2017-10-27 | 75.25x |
| 2017-10-26 | 73.78x |
| 2017-10-25 | 77.25x |
| 2017-10-24 | 77.02x |
| 2017-10-23 | 81.25x |
| 2017-10-20 | 81.77x |
| 2017-10-19 | 81.55x |
| 2017-10-18 | 79.21x |
| 2017-10-17 | 78.72x |
| 2017-10-16 | 77.17x |
| 2017-10-13 | 79.36x |
| 2017-10-12 | 85.09x |
| 2017-10-11 | 82.15x |
| 2017-10-10 | 86.30x |
| 2017-10-09 | 85.58x |
| 2017-10-06 | 85.55x |
| 2017-10-05 | 85.51x |
| 2017-10-04 | 79.85x |
| 2017-10-03 | 87.54x |
| 2017-10-02 | 83.85x |
| 2017-09-29 | 81.77x |
| 2017-09-28 | 78.49x |
| 2017-09-27 | 66.38x |
| 2017-09-26 | 67.78x |
| 2017-09-25 | 70.91x |
| 2017-09-22 | 77.40x |
| 2017-09-21 | 78.57x |
| 2017-09-20 | 76.23x |
| 2017-09-19 | 74.30x |
| 2017-09-18 | 71.81x |
| 2017-09-15 | 70.19x |
| 2017-09-14 | 70.80x |
| 2017-09-13 | 70.72x |
| 2017-09-12 | 66.38x |
| 2017-09-11 | 66.57x |
| 2017-09-08 | 66.99x |
| 2017-09-07 | 67.40x |
| 2017-09-06 | 65.48x |
| 2017-09-05 | 66.80x |
| 2017-09-01 | 68.87x |
| 2017-08-31 | 70.83x |
| 2017-08-30 | 71.40x |
| 2017-08-29 | 69.97x |
| 2017-08-28 | 69.40x |
| 2017-08-25 | 63.25x |
| 2017-08-24 | 64.80x |
| 2017-08-23 | 60.80x |
| 2017-08-22 | 60.65x |
| 2017-08-21 | 58.42x |
| 2017-08-18 | 58.46x |
| 2017-08-17 | 62.12x |
| 2017-08-16 | 69.44x |
| 2017-08-15 | 69.10x |
| 2017-08-14 | 78.57x |
| 2017-08-11 | 74.00x |
| 2017-08-10 | 65.59x |
| 2017-08-09 | 13.44x |
| 2017-08-08 | 14.66x |
| 2017-08-07 | 14.32x |
| 2017-08-04 | 12.17x |
| 2017-08-03 | 12.42x |
| 2017-08-02 | 10.43x |
| 2017-08-01 | 11.24x |
| 2017-07-31 | 11.97x |
| 2017-07-28 | 12.28x |
| 2017-07-27 | 10.56x |
| 2017-07-26 | 10.53x |
| 2017-07-25 | 11.13x |
| 2017-07-24 | 11.14x |
| 2017-07-21 | 10.44x |
| 2017-07-20 | 10.33x |
| 2017-07-19 | 10.51x |
| 2017-07-18 | 9.93x |
| 2017-07-17 | 11.08x |
| 2017-07-14 | 12.50x |
| 2017-07-13 | 13.07x |
| 2017-07-12 | 12.47x |
| 2017-07-11 | 12.14x |
| 2017-07-10 | 11.93x |
| 2017-07-07 | 12.33x |
| 2017-07-06 | 12.11x |
| 2017-07-05 | 12.79x |
| 2017-07-03 | 12.68x |
| 2017-06-30 | 11.78x |
| 2017-06-29 | 12.25x |
| 2017-06-28 | 13.46x |
| 2017-06-27 | 12.69x |
| 2017-06-26 | 13.42x |
| 2017-06-23 | 13.40x |
| 2017-06-22 | 12.83x |
| 2017-06-21 | 11.96x |
| 2017-06-20 | 11.53x |
| 2017-06-19 | 11.83x |
| 2017-06-16 | 11.08x |
| 2017-06-15 | 10.18x |
| 2017-06-14 | 10.69x |
| 2017-06-13 | 10.75x |
| 2017-06-12 | 10.79x |
| 2017-06-09 | 10.31x |
| 2017-06-08 | 10.99x |
| 2017-06-07 | 10.20x |
| 2017-06-06 | 8.18x |
| 2017-06-05 | 7.49x |
| 2017-06-02 | 8.21x |
| 2017-06-01 | 7.85x |
| 2017-05-31 | 7.45x |
| 2017-05-30 | 7.57x |
| 2017-05-26 | 10.17x |
| 2017-05-25 | 11.13x |
| 2017-05-24 | 12.39x |
| 2017-05-23 | 12.50x |
| 2017-05-22 | 12.71x |
| 2017-05-19 | 13.35x |
| 2017-05-18 | 14.48x |
| 2017-05-17 | 13.11x |
| 2017-05-16 | 13.89x |
